/PRNewswire/ The enrollment of the 52-week Phase II clinical trial of thyroid hormone receptor β (THRβ) agonist ASC41 developed in house by Gannex Pharma Co..
Главврач Домодедовской больницы: У нас никто не отказался идти в красную зону rg.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rg.ru Daily Mail and Mail on Sunday newspapers.